Literature DB >> 18085551

Haplotype analysis of the IGF2-INS-TH gene cluster in Parkinson's disease.

Greg Sutherland1, George Mellick, Jeremy Newman, Kay L Double, Julia Stevens, Linda Lee, Dominic Rowe, Peter Silburn, Glenda M Halliday.   

Abstract

Idiopathic Parkinson's disease is a common movement disorder characterized by a loss of dopaminergic neurons in the substantia nigra. Its pathogenesis is postulated to involve complex interactions between genetic susceptibility and environmental exposures. The IGF2-INS-TH gene cluster on the telomeric end of human chromosome 11 is a gene rich region expressing several proteins important for dopamine neuron homeostasis. We used a haplotyping approach to determine whether common genetic variation in the IGF2-INS-TH cluster influences the risk of idiopathic Parkinson's disease in a Caucasian case-control group recruited from Brisbane, Australia. Three tagging polymorphisms, the SNPs, rs680 and rs689 and the microsatellite, HUMTH01, were genotyped in 215 cases and 215 age- and gender-matched controls. Eight common haplotypes accounted for 91% of the genetic variation in our control group and one haplotype, IGF2-INS-TH*6, was significantly under-represented among the cases with idiopathic Parkinson's disease (OR = 0.42, 95% CI = 0.25-0.72, P-value = 0.001). Analysis of the individual polymorphisms showed that the IGF2-rs680 alternate 'A' allele accounted for the majority of the protective effect. Our findings suggest that common genetic variants in the IGF2-INS-TH cluster modify susceptibility to idiopathic Parkinson's disease. (c) 2007 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18085551     DOI: 10.1002/ajmg.b.30633

Source DB:  PubMed          Journal:  Am J Med Genet B Neuropsychiatr Genet        ISSN: 1552-4841            Impact factor:   3.568


  7 in total

1.  Euglycemic agent-mediated hypothalamic transcriptomic manipulation in the N171-82Q model of Huntington disease is related to their physiological efficacy.

Authors:  Bronwen Martin; Wayne Chadwick; Wei-na Cong; Nick Pantaleo; Caitlin M Daimon; Erin J Golden; Kevin G Becker; William H Wood; Olga D Carlson; Josephine M Egan; Stuart Maudsley
Journal:  J Biol Chem       Date:  2012-07-20       Impact factor: 5.157

2.  Genetic associations with reflexive visual attention in infancy and childhood.

Authors:  Rebecca A Lundwall; James L Dannemiller; H Hill Goldsmith
Journal:  Dev Sci       Date:  2015-11-27

Review 3.  Tyrosine hydroxylase gene: another piece of the genetic puzzle of Parkinson's disease.

Authors:  Guney Bademci; Jeffery M Vance; Liyong Wang
Journal:  CNS Neurol Disord Drug Targets       Date:  2012-06-01       Impact factor: 4.388

4.  Insulin-like growth factor 2 and autophagy gene expression alteration arise as potential biomarkers in Parkinson's disease.

Authors:  Denisse Sepúlveda; Felipe Grunenwald; Alvaro Vidal; Paulina Troncoso-Escudero; Marisol Cisternas-Olmedo; Roque Villagra; Pedro Vergara; Carlos Aguilera; Melissa Nassif; Rene L Vidal
Journal:  Sci Rep       Date:  2022-02-07       Impact factor: 4.379

5.  A cross-study transcriptional analysis of Parkinson's disease.

Authors:  Greg T Sutherland; Nicholas A Matigian; Alistair M Chalk; Matthew J Anderson; Peter A Silburn; Alan Mackay-Sim; Christine A Wells; George D Mellick
Journal:  PLoS One       Date:  2009-03-23       Impact factor: 3.240

6.  Mining for Candidate Genes Related to Pancreatic Cancer Using Protein-Protein Interactions and a Shortest Path Approach.

Authors:  Fei Yuan; Yu-Hang Zhang; Sibao Wan; ShaoPeng Wang; Xiang-Yin Kong
Journal:  Biomed Res Int       Date:  2015-11-03       Impact factor: 3.411

7.  LncRNA H19 diminishes dopaminergic neuron loss by mediating microRNA-301b-3p in Parkinson's disease via the HPRT1-mediated Wnt/β-catenin signaling pathway.

Authors:  Jingjing Jiang; Xuanyu Piao; Siying Hu; Jingbo Gao; Min Bao
Journal:  Aging (Albany NY)       Date:  2020-05-20       Impact factor: 5.955

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.